A research team at the Complutense University of Madrid has reported a major advance in the prevention of eosinophilic allergic asthma with the experimental vaccine MV130.
The findings, published in Nature Communications, mark the first time the v
Already registered? Log in
This article is free for you...
We're glad you're enjoying the Spanish Eye. Register a
free account to gain unlimited access and get more of Spain's top stories sent to you by newsletter.
By submitting your email address you agree for The Spanish Eye to send you communication by email